Interleukin-6 is a growth factor for nonmalignant human plasmablasts
Open Access
- 15 March 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 97 (6) , 1817-1822
- https://doi.org/10.1182/blood.v97.6.1817
Abstract
Interleukin-6 (IL-6), although often regarded as a B-cell differentiation factor, was recently described as the essential survival factor for human plasmablasts in vivo in reactive plasmacytosis. The present study reinvestigated the roles of IL-6 and IL-2 in the generation of plasma cells from human memory B cells in vitro. The cells involved in this differentiation process were identified as preplasmablasts (CD20±CD38±CD138−), plasmablasts (CD20−CD38++CD138−), and early plasma cells (CD20−CD38+++CD138+++). IL-2 or IL-10 induced a strong generation of plasmablasts and early plasma cells (PCs). Compared to IL-2 or IL-10, IL-6 alone was inefficient at PC generation. However, when combined with IL-2 or IL-10, IL-6 enhanced generation of early PCs. Moreover, anti–IL-6 monoclonal antibody markedly reduced IL-2–induced generation of early plasma cells, but not of plasmablasts. These roles of IL-2 and IL-6 were consistent with the difference in the expression of their respective receptors (R). CD25 (IL-2Rα) was increased 72 ± 10-fold on activated B cells, but decreased and then disappeared on plasmablasts. Conversely, CD126 (IL-6Rα) was barely expressed on activated B cells, but increased 18 ± 2-fold on preplasmablasts. Finally, IL-6 enhanced the proliferation (2-fold increase) of IL-2–generated plasmablasts. In conclusion, the data indicate that IL-6 is a growth factor for nonmalignant human plasmablasts.Keywords
This publication has 40 references indexed in Scilit:
- Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop.Journal of Clinical Investigation, 1996
- A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1British Journal of Haematology, 1996
- T cell-induced B cell blasts differentiate into plasma cells when cultured on bone marrow stroma with IL-3 and IL-10International Immunology, 1995
- The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium.Journal of Clinical Investigation, 1995
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes.The Journal of Experimental Medicine, 1993
- Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs.The Journal of Experimental Medicine, 1993
- Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.The Journal of Experimental Medicine, 1991
- The roles of interleukin 2 and interferon‐γ in human B cell activation, growth and differentiationEuropean Journal of Immunology, 1986